← Open Payments lookup

AMBAREEN SALAM: Open Payments

NPI 1053350488 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$702 in 35 payments from 13 companies in 2025. Trend: 2023 $17 · 2024 $412 · 2025 $702

Food & beverage: $702
CompanyPaymentsAmount
Novo Nordisk Inc16$298
Amgen Inc.4$81
Cleerly, Inc.1$59
SANOFI-AVENTIS U.S. LLC2$40
Exact Sciences Corporation2$39
Lilly USA, LLC2$38
Bayer Healthcare Pharmaceuticals Inc.2$30
Abbott Laboratories1$24
Boehringer Ingelheim Pharmaceuticals, Inc.1$23
AstraZeneca Pharmaceuticals LP1$23

Products named: Wegovy, Ozempic, OTEZLA, Rybelsus, Cleerly Ischemia, TZIELD, Cologuard Collection Kit, Kerendia.

Industry payments across TX — which companies pay providers there.